July 15, 2005 — The U.S. Food and Drug Administration (FDA) has approved single- and dual-chamber versions of an implantable cardioverter defibrillator that feature managed ventricular pacing and ...

The investigational device evaluated in the trial, previously known as the GORE ® VIAFORT Vascular Stent, will now be referred to as the GORE ® VIABAHN ® FORTEGRA Venous Stent. CAUTION: ...

New device size comes in response to physicians’ requests for additional offerings to expand treatment options FLAGSTAFF, Ariz.,W. L. Gore & Associates (Gore) today announced the availability of a new ...

The GORE VIABAHN Endoprosthesis portfolio spans a wide variety of sizes, including the recently added 7.5 cm and 25 cm length versions, the industry’s longest such device. The dynamic range of options ...

FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates (Gore) today announced that the Food and Drug Administration (FDA) has granted indication for the GORE® VIABAHN® Endoprosthesis to treat ...

FLAGSTAFF, Ariz., W. L. Gore & Associates (Gore) announces that the first patients are now enrolled in the Gore RELINE MAX Clinical Study, a post-approval study to continue to evaluate the GORE® ...

Gore won FDA approval for its VIABAHN VBX endoprosthesis to be used in the iliac arteries, making it the only balloon expandable stent graft having such an indication. It can be used on new or ...

The EMBRACE Registry aims to evaluate safety and performance of the GORE ® VIABAHN ® VBX Balloon Expandable Endoprosthesis when used as a bridging stent with branched and fenestrated endografts in the ...

Die Indikationserweiterung der GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis bringt das erste Bridging Stent Device mit dualer Indikation sowohl für fenestrierte als auch verzweigte ...

The MarketWatch News Department was not involved in the creation of this content. The investigational device evaluated in the trial, previously known as the GORE(R) VIAFORT Vascular Stent, will now be ...